Guideline for the Treatment of Breakthrough and the Prevention of Refractory Chemotherapy-Induced Nausea and Vomiting in Children With Cancer

被引:58
作者
Flank, Jacqueline [1 ,2 ]
Robinson, Paula D. [3 ]
Holdsworth, Mark [4 ]
Phillips, Robert [5 ,6 ]
Portwine, Carol [7 ]
Gibson, Paul [8 ]
Maan, Cathy [8 ]
Stefin, Nancy [7 ]
Sung, Lillian [9 ,10 ]
Dupuis, L. Lee [1 ,2 ,10 ]
机构
[1] Hosp Sick Children, Dept Pharm, Toronto, ON, Canada
[2] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada
[3] Pediat Oncol Grp Ontario, Toronto, ON, Canada
[4] Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA
[5] Leeds Childrens Hosp, Reg Dept Haematol & Oncol, Leeds, W Yorkshire, England
[6] Univ York, Ctr Reviews & Disseminat, York, N Yorkshire, England
[7] McMaster Univ, Dept Pediat, Div Hematol Oncol, Hamilton, ON, Canada
[8] Childrens Hosp, Pediat Hematol Oncol, London Hlth Sci Ctr, London, ON, Canada
[9] Hosp Sick Children, Dept Pediat, Div Haematol Oncol, Toronto, ON, Canada
[10] Hosp Sick Children, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada
基金
英国医学研究理事会;
关键词
chemotherapy-induced nausea; chemotherapy-induced vomiting; clinical practice guideline; supportive care; HIGHLY EMETOGENIC CHEMOTHERAPY; DOUBLE-BLIND; ANTINEOPLASTIC MEDICATION; APREPITANT; EMESIS; ADOLESCENTS; OLANZAPINE; EFFICACY; GRADE; RECOMMENDATIONS;
D O I
10.1002/pbc.25955
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This clinical practice guideline provides an approach to the treatment of breakthrough chemotherapy-induced nausea and vomiting (CINV) and the prevention of refractory CINV in children. It was developed by an international, interprofessional panel and is based on systematic literature reviews. Evidence-based interventions for the treatment of breakthrough and prophylaxis of refractory CINV are recommended. Gaps in the evidence used to support the recommendations made in this clinical practice guideline were identified. The contribution of these recommendations to breakthrough and refractory CINV control in children requires prospective evaluation. (C) 2016 Wiley Periodicals, Inc.
引用
收藏
页码:1144 / 1151
页数:8
相关论文
共 37 条
[1]  
Basch E, 2011, J CLIN ONCOL, V29, P4189, DOI [10.1200/JOP.2011.000397, 10.1200/JCO.2010.34.4614]
[2]   Emesis control by aprepitant in children and adolescents with chemotherapy [J].
Bauters, Tiene G. M. ;
Verlooy, Joris ;
Robays, Hugo ;
Benoit, Yves ;
Laureys, Genevieve .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) :1021-1024
[3]   Safety and Efficacy of Aprepitant for Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients: A Prospective, Observational Study [J].
Bodge, Megan ;
Shillingburg, Alexandra ;
Paul, Stephan ;
Biondo, Lisa .
PEDIATRIC BLOOD & CANCER, 2014, 61 (06) :1111-1113
[4]  
Chanthawong Suthan, 2014, Journal of the Medical Association of Thailand, V97, P349
[5]   Aprepitant Use in Children, Adolescents, and Young Adults for the Control of Chemotherapy-Induced Nausea and Vomiting (CINV) [J].
Choi, Mi Rim ;
Jiles, Cynthia ;
Seibel, Nita L. .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2010, 32 (07) :E268-E271
[6]   Electroacupuncture for refractory acute emesis caused by chemotherapy [J].
Choo, Su-Pin ;
Kong, Keng-He ;
Lim, Wan-Teck ;
Gao, Fei ;
Chua, Karen ;
Leong, Swan-Swan .
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2006, 12 (10) :963-969
[7]   Effective cross-over to granisetron after failure to ondansetron, a randomized double blind study in patients failing ondansetron plus dexamethasone during the first 24 hours following highly emetogenic chemotherapy [J].
de Wit, R ;
de Boer, AC ;
von der Linden, GHM ;
Stoter, G ;
Sparreboom, A ;
Verweij, J .
BRITISH JOURNAL OF CANCER, 2001, 85 (08) :1099-1101
[8]   Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients [J].
Dupuis, L. Lee ;
Robinson, Paula D. ;
Boodhan, Sabrina ;
Holdsworth, Mark ;
Portwine, Carol ;
Gibson, Paul ;
Phillips, Robert ;
Maan, Cathy ;
Stefin, Nancy ;
Sung, Lillian .
PEDIATRIC BLOOD & CANCER, 2014, 61 (08) :1506-1512
[9]   Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients [J].
Dupuis, L. Lee ;
Boodhan, Sabrina ;
Holdsworth, Mark ;
Robinson, Paula D. ;
Hain, Richard ;
Portwine, Carol ;
O'Shaughnessy, Erin ;
Sung, Lillian .
PEDIATRIC BLOOD & CANCER, 2013, 60 (07) :1073-1082
[10]   Guideline for the Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients [J].
Dupuis, L. Lee ;
Boodhan, Sabrina ;
Sung, Lillian ;
Portwine, Carol ;
Hain, Richard ;
McCarthy, Patricia ;
Holdsworth, Mark .
PEDIATRIC BLOOD & CANCER, 2011, 57 (02) :191-198